A Multicentre, EU-wide, Non-Interventional Post-Authorisation Study to Assess the Safety and Usage of Delamanid In Routine Medical Practice in Multidrug-Resistant Tuberculosis Patients.

10/08/2015
29/07/2024
EU PAS number:
EUPAS10618
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

242-12-402 PASS Protocol_Final_Version 3.0_dated 30-Oct-2015

English (528.07 KB - PDF) View document
Study results
Study results

Otsuka 242-12-402_PASS CSR_Amd. 1_Redacted

English (3.8 MB - PDF) View document

Otsuka 242-12-402_PASS CSR_Redacted

English (3.43 MB - PDF) View document
Study report
Other information
Study, other information

Otsuka 242-12-402_PASS CSR_Abstract

English (197.37 KB - PDF) View document